0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhaler Corticosteroid Device Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19D14675
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Inhaler Corticosteroid Device Market Research Report 2023
BUY CHAPTERS

Global Inhaler Corticosteroid Device Market Research Report 2025

Code: QYRE-Auto-19D14675
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhaler Corticosteroid Device Market Size

The global market for Inhaler Corticosteroid Device was valued at US$ 652 million in the year 2024 and is projected to reach a revised size of US$ 906 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Inhaler Corticosteroid Device Market

Inhaler Corticosteroid Device Market

North American market for Inhaler Corticosteroid Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inhaler Corticosteroid Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inhaler Corticosteroid Device include Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaler Corticosteroid Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Corticosteroid Device.
The Inhaler Corticosteroid Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaler Corticosteroid Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaler Corticosteroid Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhaler Corticosteroid Device Market Report

Report Metric Details
Report Name Inhaler Corticosteroid Device Market
Accounted market size in year US$ 652 million
Forecasted market size in 2031 US$ 906 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Academic and Research Institutes
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, Sumitomo Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inhaler Corticosteroid Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inhaler Corticosteroid Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inhaler Corticosteroid Device Market growing?

Ans: The Inhaler Corticosteroid Device Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Inhaler Corticosteroid Device Market size in 2031?

Ans: The Inhaler Corticosteroid Device Market size in 2031 will be US$ 906 million.

Who are the main players in the Inhaler Corticosteroid Device Market report?

Ans: The main players in the Inhaler Corticosteroid Device Market are Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, Sumitomo Corporation

What are the Application segmentation covered in the Inhaler Corticosteroid Device Market report?

Ans: The Applications covered in the Inhaler Corticosteroid Device Market report are Hospitals and Clinics, Academic and Research Institutes

What are the Type segmentation covered in the Inhaler Corticosteroid Device Market report?

Ans: The Types covered in the Inhaler Corticosteroid Device Market report are Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, Mometasone

Recommended Reports

Respiratory Devices

Corticosteroid & Asthma

Other Market Devices

1 Inhaler Corticosteroid Device Market Overview
1.1 Product Definition
1.2 Inhaler Corticosteroid Device by Type
1.2.1 Global Inhaler Corticosteroid Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Beclomethasone Dipropionate
1.2.3 Budesonide
1.2.4 Fluticasone Inhaler Powder
1.2.5 Mometasone
1.3 Inhaler Corticosteroid Device by Application
1.3.1 Global Inhaler Corticosteroid Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutes
1.4 Global Inhaler Corticosteroid Device Market Size Estimates and Forecasts
1.4.1 Global Inhaler Corticosteroid Device Revenue 2020-2031
1.4.2 Global Inhaler Corticosteroid Device Sales 2020-2031
1.4.3 Global Inhaler Corticosteroid Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhaler Corticosteroid Device Market Competition by Manufacturers
2.1 Global Inhaler Corticosteroid Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhaler Corticosteroid Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhaler Corticosteroid Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhaler Corticosteroid Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaler Corticosteroid Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaler Corticosteroid Device, Product Type & Application
2.7 Global Key Manufacturers of Inhaler Corticosteroid Device, Date of Enter into This Industry
2.8 Global Inhaler Corticosteroid Device Market Competitive Situation and Trends
2.8.1 Global Inhaler Corticosteroid Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhaler Corticosteroid Device Players Market Share by Revenue
2.8.3 Global Inhaler Corticosteroid Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhaler Corticosteroid Device Market Scenario by Region
3.1 Global Inhaler Corticosteroid Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhaler Corticosteroid Device Sales by Region: 2020-2031
3.2.1 Global Inhaler Corticosteroid Device Sales by Region: 2020-2025
3.2.2 Global Inhaler Corticosteroid Device Sales by Region: 2026-2031
3.3 Global Inhaler Corticosteroid Device Revenue by Region: 2020-2031
3.3.1 Global Inhaler Corticosteroid Device Revenue by Region: 2020-2025
3.3.2 Global Inhaler Corticosteroid Device Revenue by Region: 2026-2031
3.4 North America Inhaler Corticosteroid Device Market Facts & Figures by Country
3.4.1 North America Inhaler Corticosteroid Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhaler Corticosteroid Device Sales by Country (2020-2031)
3.4.3 North America Inhaler Corticosteroid Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhaler Corticosteroid Device Market Facts & Figures by Country
3.5.1 Europe Inhaler Corticosteroid Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhaler Corticosteroid Device Sales by Country (2020-2031)
3.5.3 Europe Inhaler Corticosteroid Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaler Corticosteroid Device Market Facts & Figures by Region
3.6.1 Asia Pacific Inhaler Corticosteroid Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhaler Corticosteroid Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhaler Corticosteroid Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhaler Corticosteroid Device Market Facts & Figures by Country
3.7.1 Latin America Inhaler Corticosteroid Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhaler Corticosteroid Device Sales by Country (2020-2031)
3.7.3 Latin America Inhaler Corticosteroid Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaler Corticosteroid Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaler Corticosteroid Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhaler Corticosteroid Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhaler Corticosteroid Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhaler Corticosteroid Device Sales by Type (2020-2031)
4.1.1 Global Inhaler Corticosteroid Device Sales by Type (2020-2025)
4.1.2 Global Inhaler Corticosteroid Device Sales by Type (2026-2031)
4.1.3 Global Inhaler Corticosteroid Device Sales Market Share by Type (2020-2031)
4.2 Global Inhaler Corticosteroid Device Revenue by Type (2020-2031)
4.2.1 Global Inhaler Corticosteroid Device Revenue by Type (2020-2025)
4.2.2 Global Inhaler Corticosteroid Device Revenue by Type (2026-2031)
4.2.3 Global Inhaler Corticosteroid Device Revenue Market Share by Type (2020-2031)
4.3 Global Inhaler Corticosteroid Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhaler Corticosteroid Device Sales by Application (2020-2031)
5.1.1 Global Inhaler Corticosteroid Device Sales by Application (2020-2025)
5.1.2 Global Inhaler Corticosteroid Device Sales by Application (2026-2031)
5.1.3 Global Inhaler Corticosteroid Device Sales Market Share by Application (2020-2031)
5.2 Global Inhaler Corticosteroid Device Revenue by Application (2020-2031)
5.2.1 Global Inhaler Corticosteroid Device Revenue by Application (2020-2025)
5.2.2 Global Inhaler Corticosteroid Device Revenue by Application (2026-2031)
5.2.3 Global Inhaler Corticosteroid Device Revenue Market Share by Application (2020-2031)
5.3 Global Inhaler Corticosteroid Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc. Inhaler Corticosteroid Device Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Company Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Plc Inhaler Corticosteroid Device Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Company Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis AG Inhaler Corticosteroid Device Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Mylan NV
6.4.1 Mylan NV Company Information
6.4.2 Mylan NV Description and Business Overview
6.4.3 Mylan NV Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan NV Inhaler Corticosteroid Device Product Portfolio
6.4.5 Mylan NV Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd.
6.5.1 Teva Pharmaceutical Industries Ltd. Company Information
6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Boehringer Ingelheim International GmbH
6.6.1 Boehringer Ingelheim International GmbH Company Information
6.6.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product Portfolio
6.6.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Inhaler Corticosteroid Device Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 F. Hoffmann-La Roche Ltd.
6.8.1 F. Hoffmann-La Roche Ltd. Company Information
6.8.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.8.3 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product Portfolio
6.8.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.9 Amgen Inc.
6.9.1 Amgen Inc. Company Information
6.9.2 Amgen Inc. Description and Business Overview
6.9.3 Amgen Inc. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amgen Inc. Inhaler Corticosteroid Device Product Portfolio
6.9.5 Amgen Inc. Recent Developments/Updates
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Company Information
6.10.2 Aurobindo Pharma Description and Business Overview
6.10.3 Aurobindo Pharma Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aurobindo Pharma Inhaler Corticosteroid Device Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments/Updates
6.11 Sumitomo Corporation
6.11.1 Sumitomo Corporation Company Information
6.11.2 Sumitomo Corporation Description and Business Overview
6.11.3 Sumitomo Corporation Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sumitomo Corporation Inhaler Corticosteroid Device Product Portfolio
6.11.5 Sumitomo Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaler Corticosteroid Device Industry Chain Analysis
7.2 Inhaler Corticosteroid Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaler Corticosteroid Device Production Mode & Process Analysis
7.4 Inhaler Corticosteroid Device Sales and Marketing
7.4.1 Inhaler Corticosteroid Device Sales Channels
7.4.2 Inhaler Corticosteroid Device Distributors
7.5 Inhaler Corticosteroid Device Customer Analysis
8 Inhaler Corticosteroid Device Market Dynamics
8.1 Inhaler Corticosteroid Device Industry Trends
8.2 Inhaler Corticosteroid Device Market Drivers
8.3 Inhaler Corticosteroid Device Market Challenges
8.4 Inhaler Corticosteroid Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inhaler Corticosteroid Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inhaler Corticosteroid Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inhaler Corticosteroid Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inhaler Corticosteroid Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inhaler Corticosteroid Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inhaler Corticosteroid Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inhaler Corticosteroid Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inhaler Corticosteroid Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inhaler Corticosteroid Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inhaler Corticosteroid Device, Product Type & Application
 Table 12. Global Key Manufacturers of Inhaler Corticosteroid Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhaler Corticosteroid Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaler Corticosteroid Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhaler Corticosteroid Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inhaler Corticosteroid Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inhaler Corticosteroid Device Sales Market Share by Region (2020-2025)
 Table 19. Global Inhaler Corticosteroid Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inhaler Corticosteroid Device Sales Market Share by Region (2026-2031)
 Table 21. Global Inhaler Corticosteroid Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inhaler Corticosteroid Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Inhaler Corticosteroid Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inhaler Corticosteroid Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Inhaler Corticosteroid Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inhaler Corticosteroid Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inhaler Corticosteroid Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inhaler Corticosteroid Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inhaler Corticosteroid Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inhaler Corticosteroid Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inhaler Corticosteroid Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inhaler Corticosteroid Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inhaler Corticosteroid Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inhaler Corticosteroid Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inhaler Corticosteroid Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inhaler Corticosteroid Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inhaler Corticosteroid Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inhaler Corticosteroid Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inhaler Corticosteroid Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inhaler Corticosteroid Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inhaler Corticosteroid Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inhaler Corticosteroid Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inhaler Corticosteroid Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inhaler Corticosteroid Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inhaler Corticosteroid Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inhaler Corticosteroid Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inhaler Corticosteroid Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inhaler Corticosteroid Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inhaler Corticosteroid Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inhaler Corticosteroid Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Inhaler Corticosteroid Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Inhaler Corticosteroid Device Sales Market Share by Type (2020-2025)
 Table 53. Global Inhaler Corticosteroid Device Sales Market Share by Type (2026-2031)
 Table 54. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inhaler Corticosteroid Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Inhaler Corticosteroid Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Inhaler Corticosteroid Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inhaler Corticosteroid Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inhaler Corticosteroid Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Inhaler Corticosteroid Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Inhaler Corticosteroid Device Sales Market Share by Application (2020-2025)
 Table 63. Global Inhaler Corticosteroid Device Sales Market Share by Application (2026-2031)
 Table 64. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inhaler Corticosteroid Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Inhaler Corticosteroid Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Inhaler Corticosteroid Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inhaler Corticosteroid Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Inc. Company Information
 Table 71. Pfizer Inc. Description and Business Overview
 Table 72. Pfizer Inc. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Inc. Inhaler Corticosteroid Device Product
 Table 74. Pfizer Inc. Recent Developments/Updates
 Table 75. GlaxoSmithKline Plc Company Information
 Table 76. GlaxoSmithKline Plc Description and Business Overview
 Table 77. GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Plc Inhaler Corticosteroid Device Product
 Table 79. GlaxoSmithKline Plc Recent Developments/Updates
 Table 80. Novartis AG Company Information
 Table 81. Novartis AG Description and Business Overview
 Table 82. Novartis AG Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis AG Inhaler Corticosteroid Device Product
 Table 84. Novartis AG Recent Developments/Updates
 Table 85. Mylan NV Company Information
 Table 86. Mylan NV Description and Business Overview
 Table 87. Mylan NV Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan NV Inhaler Corticosteroid Device Product
 Table 89. Mylan NV Recent Developments/Updates
 Table 90. Teva Pharmaceutical Industries Ltd. Company Information
 Table 91. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 92. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product
 Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 95. Boehringer Ingelheim International GmbH Company Information
 Table 96. Boehringer Ingelheim International GmbH Description and Business Overview
 Table 97. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product
 Table 99. Boehringer Ingelheim International GmbH Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. AstraZeneca Inhaler Corticosteroid Device Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. F. Hoffmann-La Roche Ltd. Company Information
 Table 106. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 107. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product
 Table 109. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 110. Amgen Inc. Company Information
 Table 111. Amgen Inc. Description and Business Overview
 Table 112. Amgen Inc. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Amgen Inc. Inhaler Corticosteroid Device Product
 Table 114. Amgen Inc. Recent Developments/Updates
 Table 115. Aurobindo Pharma Company Information
 Table 116. Aurobindo Pharma Description and Business Overview
 Table 117. Aurobindo Pharma Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Aurobindo Pharma Inhaler Corticosteroid Device Product
 Table 119. Aurobindo Pharma Recent Developments/Updates
 Table 120. Sumitomo Corporation Company Information
 Table 121. Sumitomo Corporation Description and Business Overview
 Table 122. Sumitomo Corporation Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sumitomo Corporation Inhaler Corticosteroid Device Product
 Table 124. Sumitomo Corporation Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Inhaler Corticosteroid Device Distributors List
 Table 128. Inhaler Corticosteroid Device Customers List
 Table 129. Inhaler Corticosteroid Device Market Trends
 Table 130. Inhaler Corticosteroid Device Market Drivers
 Table 131. Inhaler Corticosteroid Device Market Challenges
 Table 132. Inhaler Corticosteroid Device Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhaler Corticosteroid Device
 Figure 2. Global Inhaler Corticosteroid Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inhaler Corticosteroid Device Market Share by Type: 2024 & 2031
 Figure 4. Beclomethasone Dipropionate Product Picture
 Figure 5. Budesonide Product Picture
 Figure 6. Fluticasone Inhaler Powder Product Picture
 Figure 7. Mometasone Product Picture
 Figure 8. Global Inhaler Corticosteroid Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Inhaler Corticosteroid Device Market Share by Application: 2024 & 2031
 Figure 10. Hospitals and Clinics
 Figure 11. Academic and Research Institutes
 Figure 12. Global Inhaler Corticosteroid Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Inhaler Corticosteroid Device Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Inhaler Corticosteroid Device Sales (2020-2031) & (K Units)
 Figure 15. Global Inhaler Corticosteroid Device Average Price (US$/Unit) & (2020-2031)
 Figure 16. Inhaler Corticosteroid Device Report Years Considered
 Figure 17. Inhaler Corticosteroid Device Sales Share by Manufacturers in 2024
 Figure 18. Global Inhaler Corticosteroid Device Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Inhaler Corticosteroid Device Players: Market Share by Revenue in Inhaler Corticosteroid Device in 2024
 Figure 20. Inhaler Corticosteroid Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Inhaler Corticosteroid Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Inhaler Corticosteroid Device Sales Market Share by Country (2020-2031)
 Figure 23. North America Inhaler Corticosteroid Device Revenue Market Share by Country (2020-2031)
 Figure 24. United States Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Inhaler Corticosteroid Device Sales Market Share by Country (2020-2031)
 Figure 27. Europe Inhaler Corticosteroid Device Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Inhaler Corticosteroid Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Inhaler Corticosteroid Device Revenue Market Share by Region (2020-2031)
 Figure 35. China Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Inhaler Corticosteroid Device Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Inhaler Corticosteroid Device Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Inhaler Corticosteroid Device Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Inhaler Corticosteroid Device Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Inhaler Corticosteroid Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Inhaler Corticosteroid Device by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Inhaler Corticosteroid Device by Type (2020-2031)
 Figure 54. Global Inhaler Corticosteroid Device Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Inhaler Corticosteroid Device by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Inhaler Corticosteroid Device by Application (2020-2031)
 Figure 57. Global Inhaler Corticosteroid Device Price (US$/Unit) by Application (2020-2031)
 Figure 58. Inhaler Corticosteroid Device Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network